Clinical Trial Supplies Research Report 2026: $4.33 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Nasdaq, Inc. (NDAQ)
Last nasdaq, inc. earnings: 4/22 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.nasdaq.com
Company Research
Source: Yahoo! Finance
Increased demand for biologics, CRO outsourcing, temperature-controlled logistics, and regulatory focus are growth drivers. North America leads, while Asia-Pacific shows rapid growth. Clinical Trial Supplies Market Clinical Trial Supplies Market · GlobeNewswire Inc. Dublin, April 24, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global clinical trial supplies market is on a robust growth trajectory, expanding from $2.86 billion in 2025 to an estimated $3.1 billion in 2026, reflecting a CAGR of 8.3%. This growth has been fueled by increased clinical trial activity worldwide, the expansion of multicenter trial designs, the rise of biologics and specialty drugs, and the outsourcing trend to Contract Research Organizations (CROs). The development of cold-chain logistics has further bolstered this upward trend. Looking ahead, the market is projected to reach $4.33 billion by 2030, with a CAGR o
Show less
Read more
Impact Snapshot
Event Time:
NDAQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NDAQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NDAQ alerts
High impacting Nasdaq, Inc. news events
Weekly update
A roundup of the hottest topics
NDAQ
News
- Nasdaq (NDAQ) had its "buy (b)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- AI-Powered Clinical Trial Site Feasibility Research Report 2026: $4.38 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- Rare Disease Clinical Trials Research Report 2026: $21.34 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- Ovzon AB (FRA:OVZ) Q1 2026 Earnings Call Highlights: Record Earnings and Strategic Growth [Yahoo! Finance]Yahoo! Finance
- Nasdaq Inc (NDAQ) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ... [Yahoo! Finance]Yahoo! Finance
NDAQ
Earnings
- 4/23/26 - Beat
NDAQ
Sec Filings
- 4/23/26 - Form 8-K
- 4/7/26 - Form 4
- 4/7/26 - Form 4
- NDAQ's page on the SEC website